CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
CVS HEALTH Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$92.68+0.32 (+0.35%)
Close on Oct 19, 2026
- Market cap
- $119.28B
- P/E (TTM)
- 24.6
- Dividend yield
- 2.87%
Share price
+$10.16 (+12.31%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
CVS HEALTH Corp grew revenue 7.4% to $415.09B over the twelve months to Jun 30, 2026. Operating income fell 7.4% to $8.29B, moving the operating margin from 2.3% to 2.0%. Free cash flow was $11.76B, up 146.0% from a year earlier.
Revenue
$415.09B
+7.4% vs. a year earlier
Operating income
$8.29B
-7.4% vs. a year earlier
Free cash flow
$11.76B
+146.0% vs. a year earlier
EPS, diluted
$3.77
+5.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $119.28B
- P/E ratio
- 24.6
- Price to sales
- 0.29
- Price to book
- 1.50
- Dividend yield
- 2.87%
- Free cash flow yield
- 9.86%
Fundamentals
- Revenue
- $415.09B
- Net income
- $4.89B
- EPS, diluted
- $3.77
- Free cash flow
- $11.76B
- Book value per share
- $61.93
- Diluted shares
- 1.29B
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$415.09B+7.4% YoY
Gross profit
$184.68B+6.5% YoY
Operating income
$8.29B-7.4% YoY
Net income
$4.89B+7.9% YoY
EPS, diluted
$3.77+5.3% YoY
Free cash flow
$11.76B+146.0% YoY
Reported periodTrailing twelve months